Antisense & RNAi Therapeutics Market Size, Growth, Trends and Research Analysis by TBRC
New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports
The Antisense & RNAi Therapeutics Global Market Report 2021-30
by The Business Research Company describes and explains the global antisense
& RNAi therapeutics market and covers 2015 to 2020, termed the historic
period, and 2020 to 2025, termed the forecast period, along with further
forecasts for the period 2025-2030. The report evaluates the market across each
region and for the major economies within each region.
The Antisense & RNAi Therapeutics Global Market Report 2021
covers antisense & RNAi therapeutics market drivers, antisense & RNAi
therapeutics market trends, antisense & RNAi therapeutics market segments, antisense
& RNAi therapeutics market growth rate, antisense & RNAi therapeutics market
major players, and antisense & RNAi therapeutics market size.
View Complete Report:
The antisense & RNAi therapeutics market report provides an in-depth
analysis of the impact of COVID-19 on the global antisense & RNAi
therapeutics industry, along with revised market numbers due to the effects of
the coronavirus and the expected antisense & RNAi therapeutics market
growth numbers 2021-2030.
Antisense & RNAi Therapeutics Global Market Report 2021 is the
most comprehensive report available on this market and will help gain a truly
global perspective as it covers 60 geographies. The chapter on the impact of
COVID-19 gives valuable insights on supply chain disruptions, logistical
challenges, and other economic implications of the virus on the market. The
chapter also covers markets which have been positively affected by the
pandemic.
Request For The Sample
Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
The global antisense & RNAi therapeutics market is expected to
grow from $1.11 billion in 2020 to $1.2 billion in 2021 at a compound annual
growth rate (CAGR) of 8.1%. The market is expected to reach $1.79 billion in
2025 at a CAGR of 11%.
The report covers the antisense & RNAi therapeutic market
segments-
1) By Technology: RNA Interference, Antisense RNA.
2) By Route Of Administration: Pulmonary
Delivery, Intravenous Injections, Intra-Dermal Injections, Intraperitoneal
Injections, Topical Delivery, Other Delivery Methods.
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory
Disorders, Neurological Disorders, Infectious Diseases, Other.
About The Business Research Company:
The Business Research Company is a market research
and intelligence firm that excels in company, market, and consumer research. It
has over 200 research professionals at its offices in India, the UK and the US,
as well a network of trained researchers globally. It has specialist
consultants in a wide range of industries including manufacturing, healthcare,
financial services and technology. TBRC excels in company, market, and consumer
research.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Email: info@tbrc.info
Comments
Post a Comment